Cubist Systematic Strategies, LLC Biocryst Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$19.3 Billion
Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 1,246,696 shares of BCRX stock, worth $8.83 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,246,696

Holding current value

$8.83 Million

% of portfolio

0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$7.55 - $9.06 $9.41 Million - $11.3 Million	1,246,696 New	1,246,696 $9.46 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $3.86 Million - $6.35 Million	935,132 Added 528.02%	1,112,232 $6.87 Million
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $4.23 Million - $6.62 Million	-865,812 Reduced 83.02%	177,100 $899,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $1.96 Million - $2.66 Million	392,672 Added 60.39%	1,042,912 $6.25 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $151,196 - $178,461	22,533 Added 3.59%	650,240 $4.6 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $1.22 Million - $1.54 Million	175,092 Added 38.68%	627,707 $4.42 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $3.58 Million - $5.34 Million	451,300 Added 34319.39%	452,615 $3.77 Million
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $2.07 Million - $2.79 Million	-196,728 Reduced 99.34%	1,315 $15,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $1.71 Million - $2.35 Million	158,821 Added 404.93%	198,043 $2.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $890,402 - $2.02 Million	-112,852 Reduced 74.21%	39,222 $415,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $1.66 Million - $2.83 Million	143,375 Added 1648.18%	152,074 $2.47 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $547,361 - $756,906	-48,959 Reduced 84.91%	8,699 $120,000
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $166,200 - $206,434	-11,696 Reduced 16.86%	57,658 $829,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $265,145 - $481,168	27,910 Added 67.34%	69,354 $1.1 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $3.06 Million - $5.65 Million	-415,120 Reduced 90.92%	41,444 $421,000
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $1.5 Million - $3.83 Million	444,949 Added 3830.81%	456,564 $3.4 Million
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $37,438 - $60,359	10,915 Added 1559.29%	11,615 $40,000
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $35,910 - $106,029	-18,900 Reduced 96.43%	700 $3,000
Q1 2020 May 15, 2020	BUY	$1.6 - $4.11 $27,200 - $69,870	17,000 Added 653.85%	19,600 $39,000
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $4,134 - $8,970	2,600 New	2,600 $9,000
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $67,540 - $100,769	-27,016 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $46,338 - $145,704	15,924 Added 143.56%	27,016 $102,000
Q1 2019 May 15, 2019	BUY	$7.38 - $9.72 $8,523 - $11,226	1,155 Added 11.62%	11,092 $90,000
Q4 2018 Feb 14, 2019	SELL	$6.51 - $9.6 $51,800 - $76,387	-7,957 Reduced 44.47%	9,937 $80,000
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $20,390 - $29,515	3,694 Added 26.01%	17,894 $137,000
Q2 2018 Aug 14, 2018	BUY	$4.6 - $6.52 $65,319 - $92,584	14,200 New	14,200 $81,000

Others Institutions Holding BCRX

# of Institutions

312

Shares Held

200M

Call Options Held

640K

Put Options Held

507K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.32B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Biocryst Pharmaceuticals Inc Transaction History